Effect of rolipram and dibutyryl cyclic AMP on resequestration of cytosolic calcium in FMLP-activated human neutrophils

British Journal of Pharmacology

Volumn 124, Issue 3, 1998, Pages 547-555

  Anderson, R ^a,c   Goolam Mahomed, A ^a   Theron, A J ^a   Ramafi, G ^a   Feldman, C ^b  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c Department of Immunology ^*  (South Africa)

Author keywords

Calcium efflux; Calcium influx; Dibutyryl cyclic AMP; Elastase; Neutrophils; Rolipram; Superoxide

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); BUCLADESINE; CALCIUM 45; CALCIUM ION; FORMYLMETHIONYLLEUCYLPHENYLALANINE; FURA 2; LEUKOCYTE ELASTASE; LUCIGENIN; PHOSPHODIESTERASE IV INHIBITOR; ROLIPRAM; SALBUTAMOL; SUPEROXIDE; THEOPHYLLINE;

ARTICLE; CALCIUM TRANSPORT; CHEMOLUMINESCENCE; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; ENZYME RELEASE; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; NEUTROPHIL; PRIORITY JOURNAL; RADIOMETRY; SPECTROFLUOROMETRY;

EID: 15144342064     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701849     Document Type: Article

References (34)

1. 2+-influx. J. Biol. Chem., 270, 23816-23822.
2. ANDERSON, R., FELDMAN, C., THERON, A.J., RAMAFI, G., COLE, P.J. & WILSON, R. (1996). Anti-inflammatory, membrane-stabilizing interactions of salmeterol with human neutrophils in vitro. Br. J. Pharmacol., 117, 1387-1394.
3. ANDERSON, R., GLOVER, A., KOORNHOF, H.J. & RABSON, A.R. (1976). In vitro stimulation of neutrophil motility by levamisole. Maintenance of cGMP levels in chemotactically stimulated human neutrophils. J. Immunol., 117, 428.
4. ANDERSON, R. & GOOLAM MAHOMED, A. (1997). Calcium efflux and influx in FMLP-activated human neutrophils are chronologically distinct events. Clin. Exp. Immunol., 110, 132-138.
5. BARNES, P.J. & PAUWELS, R.A. (1994). Theophylline in the management of asthma: time for reappraisal? Eur. Resp. J., 1, 579-591.
6. BEATTY, K., ROBERTIE, P., SENIOR, R.M. & TRAVIS, J. (1982). Determination of oxidized alpha-1-proteinase inhibitor in serum. J. Lab. Clin. Med., 100, 186-192.
7. 2 and ADP-induced calcium release in intact platelets. Am. J. Physiol., 249, H8-H13.
8. DALZIEL, H.H. & WESTFALL, D.P. (1994). Receptors for adenine nucleotides and nucleosides: subclassification, distribution and molecular characterization. Pharmacol. Rev., 46, 449-466.
9. 2+. Clin. Exp. Immunol., 224, 629-635.
10. 2+ influx: What is the message from the stores to the membrane? J. Lab. Clin. Med., 128, 19-26.
11. 2+ influx in human neutrophil granulocytes. J. Biol. Chem., 272, 26471-26478.
12. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem., 260, 3440-3450.
13. IANNONE, M.A., WOLBERG, G. & ZIMMERMAN, T.P. (1989). Chemotactic peptide induces cAMP elevation in human neutrophils by amplification of the adenylate cyclase response to endogenously produced adenosine. J. Biol. Chem., 264, 20177-20180.
14. 2+ extrusion from human platelets. Biochem. Biophys. Acta, 1105, 19-28.
15. 2+-handling by non-muscle cells: studies in human neutrophils and HL60 cells. Cell Calcium, 10, 351-361.
16. LADD, P.M., GOLDBERG, B.J., SMILEY, P.A. & OLSON, C.V. (1985). Receptor-specific threshold effects of cyclic AMP are involved in the regulation of enzyme release and superoxide production from human neutrophils. Biochim. Biophys. Acta, 846, 286-295.
17. LAGAST, H., LEW, D.P. & WALDVOGEL, F.A. (1984). Adenosine triphosphatase-dependent calcium pump in the plasma membrane of guinea pig and human neutrophils. J. Clin. Invest., 73, 107-115.
18. LYTTON, J., WESTLIN, M. & HANLEY, M.R. (1991). Thapsigargin inhibits the sarcoplasmic or endoplasmic reticulum Ca-ATPase family of calcium pumps. J. Biol. Chem., 266, 17067-17071.
19. MARONE, G., THOMAS, L.L. & LICHTENSTEIN, L.M. (1980). The role of agonists that activate adenylate cyclase in the control of cAMP metabolism and enzyme release by human polymorphonuclear leukocytes. J. Immunol., 125, 2277-2283.
20. MINKENBERG, I. & FERBER, E. (1984). Lucigenin-dependent chemiluminescence as a new assay for NADPH-oxidase activity in particulate fractions of human polymorphonuclear leukocytes. J. Immunol. Meth., 71, 61-67.
21. 2+ influx in human neutrophils is secondary to the emptying of intracellular calcium stores. Biochem. J., 289, 761-766.
22. MOORE, A.R. & WILLOUGHBY, D.A. (1995). The role of cAMP regulation in controlling inflammation. Clin. Exp. Immunol., 101, 387-389.
23. NIELSON, C.P. (1987). Beta-adrenergic modulation of the polymorphonuclear leukocyte respiratory burst is dependent on the mechanism of cell activation. J. Immunol., 139, 2392-2397.
24. NIELSON, C.P., CROWLEY, J.J., MORGAN, M.E. & VESTAL, R.E. (1988). Polymorphonuclear leukocyte inhibition by therapeutic-concentrations of theophylline is mediated by cyclic-3′,5′-adenosine monophosphate. Am. Rev. Resp. Dis., 137, 25-30.
25. NIELSON, C.P., VESTAL, R.E., STURM, R.J. & HEASLIP, R. (1990). Effects of selective phosphodiesterase inhibitors on the polymorphonuclear leukocyte respiratory burst. J. Allergy Clin. Immunol., 86, 801-808.
26. POLSON, J.B., KRZANOWSKI, J.J., GOLDMAN, A.L. & SZENTIVANYI, A. (1978). Inhibition of human phosphodiesterase activity by therapeutic concentrations of theophylline. Clin. Exp. Pharmacol. Physiol., 5, 535-539.
27. 2+ sequestering pools and the action of inositol 1,4,5-triphosphate. J. Biol. Chem., 259, 13777-13782.
28. SCHATZMANN, H.J. (1989). The calcium pump of the surface membrane and of the sarcoplasmic reticulum. Annu. Rev. Physiol., 51, 473-485.
29. i. Naunyn-Schmiedeberg's Arch. Pharmacol., 344, 682-690.
30. SCHWABE, U., MIYAKA, M., OHGA, Y. & DALY, J.W. (1976). 4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidine (ZK62711): a potent inhibitor of adenosine cyclic 3′,5-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain. Mol. Pharmacol., 12, 900-910.
31. 2+ uptake in human platelets by cAMP. Biochim. Biophys. Acta, 1105, 29-39.
32. TSU, R.C., ALLEN, R.A. & WONG, Y.H. (1995). Stimulation of type II adenylyl cyclase by chemoattractant formyl peptide and C5a receptors. Mol. Pharmacol., 47, 835-841.
33. ++-dependent mechanism which is independent of transmembrane activation of adenylate cyclase. J. Biol. Chem., 260, 6769-6775.
34. VILLAGRASA, V., NAVARETTE, C., SANZ, C., BERTO, L., PERPIŇÁ, M., CORTIJO, J. & MORCILLO, E.J. (1996). Inhibition of phosphodiesterase IV and intracellular calcium levels in human polymorphonuclear leukocytes. Methods Find. Exp. Clin. Pharmacol., 18, 239-245.